Overcoming tumor resistance to chemotherapy drugs has long been a challenge for oncology clinicians and researchers. Now, a new study suggests that blocking a key protein, p300, may force damaged cancer cells into a state ...
Feb 6, 2026
0
10
Tweaking a pattern of wound healing established millions of years ago may enable scar-free injury repair after surgery or trauma, Stanford Medicine researchers have found. If results from their study, which was conducted ...
Jan 22, 2026
0
51
Researchers at The University of Texas MD Anderson Cancer Center have found that renal medullary carcinoma (RMC) cells use an adaptive mechanism called "myeloid mimicry" to hide from the immune system and promote disease ...
Nov 25, 2025
0
21
Medulloblastoma (the most common malignant childhood brain tumor) is separated into four molecular groups, with Group 3 bearing the worst prognosis. By studying EP300 and CBP, critical proteins in Group 3 medulloblastoma ...
Apr 25, 2024
0
61
Immunological memory—the ability to respond to a previously encountered antigen or foreign substance with greater speed and intensity on re-exposure is a hallmark of adaptive immunity.
Mar 20, 2024
0
55
Melanoma is the deadliest form of skin cancer because of its ability to quickly grow and spread throughout the body. More than half of those with advanced melanoma will see the disease spread to the brain, where it rapidly ...
Nov 29, 2023
0
70
A new editorial perspective titled "C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells" has been published in Oncotarget.
Nov 13, 2023
0
34
A new research paper was published in Oncotarget, titled, "Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells."
Jul 24, 2023
0
30
Research led by doctors and scientists at UCLA Jonsson Comprehensive Cancer Center and the UCLA Jane & Terry Semel Institute for Neuroscience & Human Behavior have identified a gene that may provide a therapeutic target for ...
Oct 19, 2022
0
67
